Stockreport

Corcept Therapeutics Announces Third Quarter Financial Results, Oncology Development Programs and Provides Corporate Update

Corcept Therapeutics Incorporated  (CORT) 
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corcept.com/investors
PDF Revenue of $207.6 million, compared to $182.5 million in third quarter 2024Modified 2025 revenue guidance of $800 – $850 millionNet income of $19.7 million, compared to [Read more]